RANGAP1 and glioblastoma: Moreover, the study of Lin et al. [32] introduces a potential therapeutic strategy for glioblastoma through oridonin-induced downregulation of RANGAP1, leading to RNA accumulation and subsequent glioma cell apoptosis.